Intra-arterial peptide-receptor radionuclide therapy for neuro-endocrine tumour liver metastases: an in-patient randomised controlled trial (LUTIA).
Eur J Nucl Med Mol Imaging
; 51(4): 1121-1132, 2024 Mar.
Article
in En
| MEDLINE
| ID: mdl-37897617
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Organometallic Compounds
/
Neuroendocrine Tumors
/
Liver Neoplasms
Limits:
Humans
Language:
En
Journal:
Eur J Nucl Med Mol Imaging
Journal subject:
MEDICINA NUCLEAR
Year:
2024
Type:
Article
Affiliation country:
Netherlands